Cargando…
Peptide receptor radiotherapy: a new option for the management of aggressive fibromatosis on behalf of the Italian Sarcoma Group
The management of aggressive fibromatosis (AF) is problematic, and few options are available to patients unsuitable for surgery and resistant to external-beam radiation therapy (EBRT). We report on two patients with fast-growing recurrences of AF resistant to EBRT who obtained protracted clinical be...
Autores principales: | De Pas, T, Bodei, L, Pelosi, G, de Braud, F, Villa, G, Capanna, R, Paganelli, G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376350/ https://www.ncbi.nlm.nih.gov/pubmed/12618868 http://dx.doi.org/10.1038/sj.bjc.6600823 |
Ejemplares similares
-
Pazopanib: a novel treatment option for aggressive fibromatosis
por: Bulut, Gulcan, et al.
Publicado: (2016) -
Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017) -
Radiotherapy in the treatment of aggressive fibromatosis: experience from a single institution
por: Seidensaal, K., et al.
Publicado: (2020) -
An Aggressive Retroperitoneal Fibromatosis
por: Campara, Zoran, et al.
Publicado: (2016) -
Management of aggressive fibromatosis
por: Zhang, Zhijun, et al.
Publicado: (2021)